skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: {sup 18}F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT

Abstract

Purpose: Positron emission tomography (PET), in addition to computed tomography (CT), has an effect in target volume definition for radical radiotherapy (RT) for non-small-cell lung cancer (NSCLC). In previously PET-CT staged patients with NSCLC, we assessed the effect of using an additional planning PET-CT scan for gross tumor volume (GTV) definition. Methods and Materials: A total of 28 patients with Stage IA-IIIB NSCLC were enrolled. All patients had undergone staging PET-CT to ensure suitability for radical RT. Of the 28 patients, 14 received induction chemotherapy. In place of a RT planning CT scan, patients underwent scanning on a PET-CT scanner. In a virtual planning study, four oncologists independently delineated the GTV on the CT scan alone and then on the PET-CT scan. Intraobserver and interobserver variability were assessed using the concordance index (CI), and the results were compared using the Wilcoxon signed ranks test. Results: PET-CT improved the CI between observers when defining the GTV using the PET-CT images compared with using CT alone for matched cases (median CI, 0.57 for CT and 0.64 for PET-CT, p = .032). The median of the mean percentage of volume change from GTV{sub CT} to GTV{sub FUSED} was -5.21% for the induction chemotherapymore » group and 18.88% for the RT-alone group. Using the Mann-Whitney U test, this was significantly different (p = .001). Conclusion: PET-CT RT planning scan, in addition to a staging PET-CT scan, reduces interobserver variability in GTV definition for NSCLC. The GTV size with PET-CT compared with CT in the RT-alone group increased and was reduced in the induction chemotherapy group.« less

Authors:
 [1];  [2];  [3];  [4];  [3];  [5];  [3];  [5];  [6];  [4];  [3];  [1];  [2]
  1. Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, Northern Ireland (United Kingdom)
  2. (United Kingdom)
  3. Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland (United Kingdom)
  4. Northern Ireland Regional Medical Physics Agency, Royal Victoria Hospital, Belfast, Northern Ireland (United Kingdom)
  5. Northern Ireland Regional Medical Physics Agency, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland (United Kingdom)
  6. Department of Nuclear Medicine, Belfast City Hospital, Belfast, Northern Ireland (United Kingdom)
Publication Date:
OSTI Identifier:
21372235
Resource Type:
Journal Article
Resource Relation:
Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 77; Journal Issue: 1; Other Information: DOI: 10.1016/j.ijrobp.2009.04.045; PII: S0360-3016(09)00621-X; Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CAT SCANNING; CHEMOTHERAPY; FLUORINE 18; FLUORODEOXYGLUCOSE; LUNGS; NEOPLASMS; POSITRON COMPUTED TOMOGRAPHY; RADIOTHERAPY; SIMULATION; ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY; TOMOGRAPHY

Citation Formats

Hanna, Gerard G., E-mail: Gerry.Hanna@googlemail.co, Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, McAleese, Jonathan, Carson, Kathryn J., Stewart, David P., Cosgrove, Vivian P., Eakin, Ruth L., Zatari, Ashraf, Lynch, Tom, Jarritt, Peter H., Young, V.A. Linda D.C.R., O'Sullivan, Joe M., and Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. {sup 18}F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT. United States: N. p., 2010. Web. doi:10.1016/j.ijrobp.2009.04.045.
Hanna, Gerard G., E-mail: Gerry.Hanna@googlemail.co, Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, McAleese, Jonathan, Carson, Kathryn J., Stewart, David P., Cosgrove, Vivian P., Eakin, Ruth L., Zatari, Ashraf, Lynch, Tom, Jarritt, Peter H., Young, V.A. Linda D.C.R., O'Sullivan, Joe M., & Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. {sup 18}F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT. United States. doi:10.1016/j.ijrobp.2009.04.045.
Hanna, Gerard G., E-mail: Gerry.Hanna@googlemail.co, Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, McAleese, Jonathan, Carson, Kathryn J., Stewart, David P., Cosgrove, Vivian P., Eakin, Ruth L., Zatari, Ashraf, Lynch, Tom, Jarritt, Peter H., Young, V.A. Linda D.C.R., O'Sullivan, Joe M., and Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. Sat . "{sup 18}F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT". United States. doi:10.1016/j.ijrobp.2009.04.045.
@article{osti_21372235,
title = {{sup 18}F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT},
author = {Hanna, Gerard G., E-mail: Gerry.Hanna@googlemail.co and Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland and McAleese, Jonathan and Carson, Kathryn J. and Stewart, David P. and Cosgrove, Vivian P. and Eakin, Ruth L. and Zatari, Ashraf and Lynch, Tom and Jarritt, Peter H. and Young, V.A. Linda D.C.R. and O'Sullivan, Joe M. and Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland},
abstractNote = {Purpose: Positron emission tomography (PET), in addition to computed tomography (CT), has an effect in target volume definition for radical radiotherapy (RT) for non-small-cell lung cancer (NSCLC). In previously PET-CT staged patients with NSCLC, we assessed the effect of using an additional planning PET-CT scan for gross tumor volume (GTV) definition. Methods and Materials: A total of 28 patients with Stage IA-IIIB NSCLC were enrolled. All patients had undergone staging PET-CT to ensure suitability for radical RT. Of the 28 patients, 14 received induction chemotherapy. In place of a RT planning CT scan, patients underwent scanning on a PET-CT scanner. In a virtual planning study, four oncologists independently delineated the GTV on the CT scan alone and then on the PET-CT scan. Intraobserver and interobserver variability were assessed using the concordance index (CI), and the results were compared using the Wilcoxon signed ranks test. Results: PET-CT improved the CI between observers when defining the GTV using the PET-CT images compared with using CT alone for matched cases (median CI, 0.57 for CT and 0.64 for PET-CT, p = .032). The median of the mean percentage of volume change from GTV{sub CT} to GTV{sub FUSED} was -5.21% for the induction chemotherapy group and 18.88% for the RT-alone group. Using the Mann-Whitney U test, this was significantly different (p = .001). Conclusion: PET-CT RT planning scan, in addition to a staging PET-CT scan, reduces interobserver variability in GTV definition for NSCLC. The GTV size with PET-CT compared with CT in the RT-alone group increased and was reduced in the induction chemotherapy group.},
doi = {10.1016/j.ijrobp.2009.04.045},
journal = {International Journal of Radiation Oncology, Biology and Physics},
number = 1,
volume = 77,
place = {United States},
year = {Sat May 01 00:00:00 EDT 2010},
month = {Sat May 01 00:00:00 EDT 2010}
}